| Issue |
J Extra Corpor Technol
Volume 41, Number 1, March 2009
|
|
|---|---|---|
| Page(s) | 37 - 40 | |
| DOI | https://doi.org/10.1051/ject/200941037 | |
| Published online | 15 March 2009 | |
Abstract
Extracorporeal Membrane Oxygenation for the Management of Respiratory Failure Caused by Diffuse Alveolar Hemorrhage
* Department of Extracorporeal Circulation, Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China
† Department of Respiratory Diseases, Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China
Address correspondence to: Xin Li, MD, Department of Extracorporeal Circulation, No. 241, West Huaihai Road, Shanghai 200030, China. E-mail: leex21@hotmail.com
Extracorporeal membrane oxygenation (ECMO) was developed as a supportive therapy to treat severe respiratory failure. When conventional mechanical ventilation has failed or when there is not enough time to treat the pathology, ECMO has the potential to sustain life. In this report, successful use of ECMO to support an adult patient with antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitides complicated by severe respiratory failure caused by diffuse alveolar hemorrhage will be discussed.
Key words: extracorporeal membrane oxygenation / diffuse alveolar hemorrhage / systemic vasculitides / respiratory failure
© 2009 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.